Psoriasis inducida por docetaxel

Allende, I.; González-Hermosa, M.R.; Lázaro, Milagros; Díaz‐Pérez, J.L.

doi:10.1016/s0001-7310(09)71919-2

Cited by 4 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As CD4 + and CD8 + T-cells are well known for their role in the pathogenesis of psoriasis, this suggests the possible underlying mechanism of docetaxel-aggravated psoriasis. To our knowledge, no previous reports have described docetaxel-induced aggravation of psoriasis; the 2 aforementioned reports described cases that presented with de no-vo psoriasis after docetaxel use 2,3 . Ours is the first report to describe a case of docetaxel-induced aggravation of psoriasis.…”

Section: Department Of Dermatology Seoul National University Collegementioning

confidence: 97%

“…Various cutaneous adverse effects associated with its use include hand-foot syndrome and radiation recall dermatitis 1 . However, only 2 cases of docetaxel-induced psoriasiform eruptions have been reported 2,3 . These 2 patients demonstrated newly developed psoriasis 2∼4 days after docetaxel administration.…”

Section: Department Of Dermatology Seoul National University Collegementioning

confidence: 99%

See 1 more Smart Citation

Docetaxel-Aggravated Psoriasis

et al. 2019

View full text Add to dashboard Cite

Section: Department Of Dermatology Seoul National University Collegementioning

confidence: 97%

Section: Department Of Dermatology Seoul National University Collegementioning

confidence: 99%

Docetaxel-Aggravated Psoriasis

et al. 2019

View full text Add to dashboard Cite

Psoriasis induit par le docétaxel

Kérob

Maignan

Vignon-Pennamen

et al. 2010

Annales de Dermatologie et de Vénéréologie

View full text Add to dashboard Cite

Development of psoriasis during docetaxel therapy in a patient with non‐small‐cell lung cancer

Watabe

Amano

2020

The Journal of Dermatology

View full text Add to dashboard Cite

confluent rash on the patient's trunk and on the flexor surfaces of his arms and legs (Fig. 1a,b). Petechiae were not apparent. He had neither itching nor pain, and no systemic lymphadenopathy was observed. A drug allergy was not suspected based on his recent medication history, and measles and rubella were ruled out by antibody tests. Laboratory data revealed a white blood cell count of 2.8 9 10 3 /L, hemoglobin level of 15.5 g/dL and platelet count of 153 9 10 3 /µL, which was less than half of his baseline platelet count. Although the rash appeared to be similar to that developed under dengue fever, his dengue virus NS1 antigen test was negative. On admission, the patient did not complain of respiratory symptoms but had mild hypoxemia, for which he underwent chest computed tomography. Imaging results suggested COVID-19,

show abstract

Psoriasis inducida por docetaxel

Cited by 4 publications

References 9 publications

Docetaxel-Aggravated Psoriasis

Docetaxel-Aggravated Psoriasis

Psoriasis induit par le docétaxel

Development of psoriasis during docetaxel therapy in a patient with non‐small‐cell lung cancer

Contact Info

Product

Resources

About